Formulation of oxybutynin chloride microparticle-loaded suppositories: in vitro characterization and in vivo pharmacokinetic study
Abstract Background Oxybutynin chloride (OXC) is used to treat overactive urinary bladder. OXC is metabolized in the liver to N-desethyloxybutynin, which is mainly responsible for the anticholinergic side effects of OXC. Conventional oxybutynin suppositories formulated earlier have shown most common...
Main Authors: | Anjali Bedse, Hitendra Mahajan, Suchita Dhamane |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2022-03-01
|
Series: | Future Journal of Pharmaceutical Sciences |
Subjects: | |
Online Access: | https://doi.org/10.1186/s43094-022-00411-x |
Similar Items
-
THE OXYBUTYNIN ABUSE IN ADOLESCENT CASE
by: Kardas Omer, et al.
Published: (2019-05-01) -
Is Oxybutynin Treatment as Effective as Surgery in Palmar and Axillary Hyperhidrosis?
by: Celal Buğra Sezen, et al.
Published: (2017-09-01) -
Insights into the Management of Overactive Bladder with Transdermal Oxybutynin: A Practical Review
by: Vozmediano-Chicharro R, et al.
Published: (2020-08-01) -
Desmopressin versus Oxybutynin for Nocturnal Enuresis in Children in Bandar Abbas: A Randomized Clinical Trial
by: Kambiz Ghasemi, et al.
Published: (2016-03-01) -
Formulation of Tinidazole Rectal Suppositories
by: Hala S. Yousif
Published: (2011-12-01)